Skip to main content
Market intelligence
NUVLHealthcare

Nuvalent Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jul 9, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jul 9, 2026Henry E. PelishChief Scientific OfficerSale2,111$123.81$261,363
Jul 6, 2026James Richard PorterPresident and CEOSale30,000$123.72$3,711,600
Jul 1, 2026Darlene NociChief Development OfficerSale23,000$123.59$2,842,570